Tectonic Therapeutic (TECX)
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of...
- Open
- 31.890
- High
- 37.300
- Low
- 31.890
- Prev. Close
- 31.870
- Volume
- 665.58K
- Turnover
- 23.63M
- Avg Price
- 35.510
- Bid/Ask Ratio
- 33.33%
- Amplitude
- 16.98%
- 52wk High
- 39.528
- Volume Ratio
- 4.52
- Turnover Ratio
- 5.73%
Tectonic Therapeutic Analyst Rating
View moreForecast & Rating
Aug 10, 2026Price forecast
$77.56110.58%
Forecast & RatingStrong buy
10analysts
- Strong buy90.00%
- Buy10.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Aug 7 at 06:11 PM
Tectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Estimates By $0.17 EPS
- Tip Ranks · Aug 7 at 10:28 AM
Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)
- Global Report · Aug 4 at 04:17 AM
The Misfits and the Money Machines: Inside the Market’s Weirdest Corner
- Market Beat · Jul 27 at 05:24 AM
Orbimed Advisors LLC Has $7 Million Stock Position in Tectonic Therapeutic, Inc. $TECX
- rttnews · Jul 6 at 04:55 AM
5 Biotech Stocks That Delivered 100% To 300% Gains: Did Your Winning Trades Offset Portfolio Losses?
- rttnews · Jul 3 at 12:19 AM
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
